Navigation Links
OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy
Date:11/6/2009

LEXINGTON, Ky., Nov. 6 /PRNewswire-FirstCall/ -- Virtual Health Technologies, Inc. (OTC Bulletin Board: VHGI) confirmed today that the previously confirmed Letter of Intent to sell all health care related assets to Wound Management Technologies, Inc (WNDM) is subject to final approval of the Board of Directors and shareholders of VHGI.

Shareholder Assurances

"We believe that the potential stock dividend, royalty stream and cash realized from the transaction would benefit our shareholders tremendously and allow them to participate in the profitable development of our healthcare technology divisions under a larger, more diversified and consolidated infrastructure. However, completion of this proposed sale will not occur until we are 100% confident that this transaction is in the best interest of VHGI shareholders. As developments become available during the coming due diligence period we will release updates." stated Jim Renfro, President of VHGI.

Continued Independent VHGI Healthcare Technology Operations and Growth

"VHGI's health technology divisions Medical Office Software (MOS) Inc., Secure eHealth LLC, and Veriscrip continue to operate under the independent authority of VHGI, and will do so subject to final approval by our Board of Directors and shareholder approval of the contemplated transaction. Business continues uninterrupted, and we are presently evaluating new contracts that would be unaffected by the potential transfer of any operations to WNDM," continued Renfro.

Treasure Gulch Gold Mine Developments

In a related announcement, VHGI confirmed that they are proceeding with the evaluation of the recently acquired Lease-Purchase Option Agreement for the Treasure Gulch Gold Mine in Prescott, Arizona. Unverified historical due-diligence material originally obtained from Western Sierra Mining Corp, Inc. (WSRA, a public company which is the owner of the subject
'/>"/>

SOURCE VirtualHealth Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. OTCBB-VHGI Announces LOI to Sell Certain Assets for $10 Million Cash/Stock to WNDM; With Stock Dividend to be Distributed to Shareholders in 2010
2. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
3. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain
4. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
5. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
6. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
7. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
8. BioCryst Updates Peramivir Clinical Development Plan
9. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
10. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
11. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...tlinker.comannouncesthatanewmarketresearchreportis...DevicesMarketAnalysisandForecaststo2015 ,, ht...ental-Devices-Market-Analysis-and-Forecasts-to-201...sisandForecaststo2015 ,, Summary ,, Thisre...tarelatingtotheUSdentaldevicesmarket.Italsooffersd...
(Date:11/25/2009)...all/--NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevicec...ptivesurgicaltreatmentsforthespine,announcedtodayt...09,at5:30p.m.ET/2:30p.m.PT.Theconferencecallwillfo...pany,sproductsandwillincludecommentsfrommanagement...nnumbersare1-877-407-4018fordomesticcallersand1-20...
(Date:11/25/2009)...PRNewswire-FirstCall/--HeartWareInternational,Inc....eroflessinvasive,miniaturizedcirculatorysupporttec...tfailure,todayannouncedthatitisscheduledtomakeanin...hCareConferenceat8:00amESTonWednesday,December2,20...,December1-2. ,, AlivewebcastoftheCompany,spres...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Cell Therapeutics Inc Reports Outcome of Annual Meeting of Shareholders 5626 1Cell Therapeutics Inc Reports Outcome of Annual Meeting of Shareholders 5626 2The bowels of infection 10454 1The bowels of infection 10454 2NHP Announces Third Quarter Earnings Release Date and Webcast Conference Call 59874 1NHP Announces Third Quarter Earnings Release Date and Webcast Conference Call 59874 2
...lation May Provide New Option for Clinicians Conce...ing an Oral NSAID, TAMPA, Fla., May 8 Alpharma I...aceutical company, announced today that two,studie...ociety annual,meeting demonstrate the efficacy, to... Alpharma Pharmaceuticals, FLECTOR(R) Patch (diclo...
...aluate Preferred Induction Dosing Regimen, SEATTL...RBN ) today announced that its partner, Wyeth Phar...s commenced patient dosing in the next,Phase 2b cl...d arthritis,(RA). In collaboration with Trubion, W...7 and other CD20-directed products., The randomiz...
Other Medicine Technology:Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 2Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 3Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 4Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 5Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 6Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 7Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 2Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 3Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 4
(Date:11/25/2009)....25/PRNewswire-USNewswire/--Whenmostpeoplehearthea...canalsogivepatientsthehelptheyneed.TMJstandsforthe...ble)contacts/connectswithyourskull(temporalbone). ...ctionarepainwithchewing,clickingorpoppingofthejaw....ncluding:headaches,fatigue,sleepdisturbances,irrit...
(Date:11/25/2009)...Nov.25/PRNewswire/--TheBartleHallConventionCenterw...conDec.9-10,whenKansasCityhoststhelatestinaserieso...freecliniceventhasthepotentialtobethebiggestoneyet...beheldonweekdaysinsteadofoveraweekend,"SheriWood,e...presidentoftheNationalAssociationofFreeClinics(NAF...
(Date:11/25/2009)...f.,Nov.25/PRNewswire-FirstCall/-- OnyxPharmaceuti...nywillhosttwoinvestoreventsinDecember: ,, ASH...a.m.ET ,, Principalinvestigatorswilldiscussda.../orrefractorymultiplemyeloma,asfeaturedatthe51stAm...sitioninNewOrleans,LA.Theteleconferencewillbeginat...
(Date:11/25/2009)...RY,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleadi...andsoftwareandCalgaryScientificInc.,aleadingprovid...bversionofAegis(TM)Breast4DAdvancedVisualizationso...lyzero-footprintWebclientbasedmedicalimagingofferi...rmallowsforzero-footprintaccess-requiringnosoftwar...
(Date:11/25/2009)...PRNewswire/-SentinelleMedicalInc.,aleadingmanufact...relaunchesasuiteofnewleadingedgeclinicalapplicatio...isyear,sRadiologicalSocietyofNorthAmerica(RSNA)ann...llA).Theapplicationsleveragetheuniquehighqualityim...ilsandsupportmultipleimagingmodalitiesformulti-par...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3
...venue and Earnings Guidance for 2008, - Total Reve...268.0mm for Fourth Qua...p 16% to $1.59 for Full Year, (GAAP EPS down 11% t...thening Across Segments, - Reconfirming 2008 Reven...
..., Calif., Feb. 28 Cardiva Medical, Inc., a,privat...he Boomerang,Catalyst(TM) System announces that it...lyst II System on February 29 at 9:20am at the Med...n in Las Vegas, NV., The Boomerang Catalyst II Sy...
...he most effective treatment for lowering cholester...be safe in large clinical trials. Although side ef...especially musculoskeletal complications, have bee... of Arthritis Care & Research ( http://www.intersc...
...r 2007 And Full Year 2007 Highlights, - Revenue ... from the, fourth quarter of 2006. Revenue for the...rease from $1.3 billion for full year 2006., - Ave...lity Operating Income for the fourth quarter grew ...
...breast cancers for three receptors could help doct...rain metastases. A study published in the open acc...ents with tumours that are negative for estrogen r...brain metastases. Survival is also correlated to t...
...eb. 27 Today, the U.S. House,Foreign Affairs Comm...PEPFAR, the U.S. Global Leadership Against HIV/AID...08., Tony Perkins, President of Family Research C...ontained in earlier drafts. Previous,drafts would ...
Other Medicine News:Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 2Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 3Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 4Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 5Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 6Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 7Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 8Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 9Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 10Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 11Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 12Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 13Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 14Health News:inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007 15Health News:Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the 'Investment in Innovation (In3) West' Conference on February 29, 2008 in Las Vegas, NV 2Health News:Tendon complications, though rare, linked to statins 2Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 2Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 3Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 4Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 5Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 6Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 7Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 8Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 9Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 10Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 11Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 12Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 13Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 14Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 15Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 16Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 17Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 18Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 19Health News:Brookdale Announces Fourth Quarter and Full Year 2007 Results 20
Lindstrom Curved Pierce Forcep
Green Straight Fixation Forceps
O'Connor-Elschnig Fixation Forceps
Pierse Type Fine Forceps
Medicine Products: